特集 神経疾患治療の進歩 2017
腫瘍性および肉芽腫性疾患の治療の進歩
2018 年 35 巻 5 号 p. 614-616
詳細
2018 年 35 巻 5 号 p. 614-616
The treatment of brain tumors and granulomatous disease in the brain represents a serious unmet medical need in the field of neuro–oncology. Even though many effective compounds have demonstrated success in treating peripheral tumors with targeted agents, one aspect of this lack of success in the brain may be related to poor delivery of otherwise effective compounds. This review discusses some issues that are pertinent to precision medicine for glioma, brain metastases and neurosarcoidosis with some reports published in 2017. In addition, we introduce the promising results in clinical trials of new–targeted immunetherapies for theses diseases.
